Alimta (Inopha)

Replacement | Medicines | 17/04/2014

The parallel distributor informed its supplied customers in a letter dated April 17, 2014, that Alimta in Italian presentation is being recalled as a precautionary measure, as it cannot be ensured that the regular distribution chain has been adhered to.

Name of the medicinal product Alimta 500 mg Pulver zur Herstellung eines Konzentrates zur Herstellung einer Infusionslösung
Marketing authorisation number(s) EU/1/04/290/001
Marketing authorisation holder Eli Lilly Nederland B.V.

Paralleldistribution und Durchführung Rückruf:
Batch number(s) C134092E, C160908C
Classification of the recall2
BASG reference number INS - 640.001 - 1087

Further inquiry note